berbamine has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, Q; Du, B; Jiang, Y; Li, C; Song, Y; Tan, Y; Wang, K; Wei, X; Xiao, J; Zhan, Y; Zhang, W; Zhao, T | 1 |
| Chen, Y; Liu, R; Qi, J; Ren, S; Xiong, D; Xushi, MY; Yang, C; Zhang, Y; Zhu, H | 1 |
2 other study(ies) available for berbamine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma; Cathepsins; Cisplatin; Humans; Hydrogen-Ion Concentration; Lung; Lung Neoplasms; Lysosomes; Mice; Reactive Oxygen Species | 2023 |
A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Breast Neoplasms; Calcium; Calmodulin; Carcinoma; CDC2 Protein Kinase; Cell Line, Tumor; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Doxorubicin; Drug Resistance, Multiple; Female; Humans; Rhodamine 123 | 2010 |